TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.

about

Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.The Genetics of Clinical Liver Diseases: Insight into the E167K Variant

P2860

Q40113130-CE7464FD-1D3A-434D-9641-33944D1CC14C Q57066897-E1C0A42C-598F-4D31-B7F0-7074716EA199

P2860

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.

Item

http://www.wikidata.org/entity/Q40482870

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

TM6SF2 E167K variant predicts ...... -3 hepatitis C virus genotype.

@en

type

Item

label

TM6SF2 E167K variant predicts ...... -3 hepatitis C virus genotype.

@en

prefLabel

TM6SF2 E167K variant predicts ...... -3 hepatitis C virus genotype.

@en

P1476

TM6SF2 E167K variant predicts ...... -3 hepatitis C virus genotype.

@en

P2093

Anna Grandone

http://www.w3.org/2001/XMLSchema#string

Carmine Minichini

http://www.w3.org/2001/XMLSchema#string

Emanuela Messina

http://www.w3.org/2001/XMLSchema#string

Emanuele Miraglia Del Giudice

http://www.w3.org/2001/XMLSchema#string

Grazia Cirillo

http://www.w3.org/2001/XMLSchema#string

Mario Starace

http://www.w3.org/2001/XMLSchema#string

Nicola Coppola

http://www.w3.org/2001/XMLSchema#string

Patrizia Morelli

http://www.w3.org/2001/XMLSchema#string

Stefania Salpietro

http://www.w3.org/2001/XMLSchema#string

P2860

TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content

Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.

Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Histological grading and staging of chronic hepatitis

Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.

Role of genetic polymorphisms in hepatitis C virus chronic infection.

Photodynamic action of proflavine on coliphage T3. I. Kinetics of inactivation.

P304

8509-8518

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V22.I38.8509

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Evangelista Sagnelli

Caterina Sagnelli

Caterina Uberti-Foppa

Marco Merli

Adriano Lazzarin

Hamid Hasson

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27784963

http://www.w3.org/2001/XMLSchema#string

P932

5064032

http://www.w3.org/2001/XMLSchema#string

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.

about

P2860

P2860

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932